Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 T-lymphocyte subpopulations in multiple sclerosis--do they help to judge immunosuppressive therapy?

Literature DB >> 2850189

T-lymphocyte subpopulations in multiple sclerosis--do they help to judge immunosuppressive therapy?

A Henneberg¹, E G Fischer, H H Kornhuber.

Abstract

T-cell subpopulations were tested in multiple sclerosis (MS) patients before and after cyclophosphamide (n = 38) and corticotropin (n = 37) treatment and physiotherapy (n = 30). There were no specific changes of subset ratios immediately after immunosuppressive treatment. However, T-cell subpopulations showed great day-to-day variations in MS patients.

Entities: Chemical Disease Species

Mesh：

Substances：

Year: 1988 PMID： 2850189 DOI： 10.1007/bf00452783

Source DB: PubMed Journal: Eur Arch Psychiatry Neurol Sci ISSN： 0175-758X

Keyword Cloud
References

19 in total

Review 1. Diagnosis and classification of multiple sclerosis.

Authors: W I McDonald; A M Halliday
Journal: Br Med Bull Date: 1977-01 Impact factor: 4.291

2. The use of cyclophosphamide in the treatment of multiple sclerosis.

Authors: H L Weiner; S L Hauser; D A Hafler; R J Fallis; J R Lehrich; D M Dawson
Journal: Ann N Y Acad Sci Date: 1984 Impact factor: 5.691

3. T-cell subsets in multiple sclerosis: a comparative study between cell surface antigens and function.

Authors: U Tjernlund; P Cesaro; E Tournier; J D Degos; J F Bach; M A Bach
Journal: Clin Immunol Immunopathol Date: 1984-08

4. Intensive immunosuppression in progressive multiple sclerosis. A randomized, three-arm study of high-dose intravenous cyclophosphamide, plasma exchange, and ACTH.

Authors: S L Hauser; D M Dawson; J R Lehrich; M F Beal; S V Kevy; R D Propper; J A Mills; H L Weiner
Journal: N Engl J Med Date: 1983-01-27 Impact factor: 91.245

T-lymphocyte subpopulations in multiple sclerosis--do they help to judge immunosuppressive therapy?

Review 1. Diagnosis and classification of multiple sclerosis.

2. The use of cyclophosphamide in the treatment of multiple sclerosis.

3. T-cell subsets in multiple sclerosis: a comparative study between cell surface antigens and function.

4. Intensive immunosuppression in progressive multiple sclerosis. A randomized, three-arm study of high-dose intravenous cyclophosphamide, plasma exchange, and ACTH.

5. Absence of day to day variation in lymphocyte subpopulations in healthy humans.

6. Cyclophosphamide: effect on experimental allergic encephalomyelitis in Lewis rats.

7. T cell subsets in multiple sclerosis. A longitudinal study of exacerbating-remitting cases.

8. Loss of suppressor T cells in active multiple sclerosis. Analysis with monoclonal antibodies.

9. The effect of cyclophosphamide on cytotoxic T-lymphocyte responses: inhibition of helper T-cell induction in vitro.

10. Peripheral blood T lymphocyte changes in multiple sclerosis: a marker of disease progression rather than of relapse?